| Previous close | 61.85 |
| Open | 61.85 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 1,080.00 |
| Expiry date | 2025-08-15 |
| Day's range | 61.85 - 61.85 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
PA Media: MoneyWeight-loss jabs ‘important for economy so people get back into work’, says PM
Sir Keir Starmer said anti-obesity medication could help boost Britain’s economy.
Investor's Business DailyHims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
Hims stock popped Monday after the FDA reportedly said it would reconsider its decision to bar compounders from selling knockoff tirzepatide.
Investor's Business DailyWhy Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade
Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already baked into the stock.
© 2024 Yahoo. All rights reserved.